logo
Select company
Select metric
$ 0Net Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
43
Sector
75
Industry
88
History
59
$ 3.52Close
$ 1.72 - $ 8.5 52-Week Range
Ticker Information

Ticker

MRVI

Company Name

MARAVAI LIFESCIENCES HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MARAVAI LIFESCIENCES HOLDINGS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRVI - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ -331K
6/30/2024$ -19K
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 696K
6/30/2023$ 1.11M
3/31/2023$ 1.63M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MARAVAI LIFESCIENCES HOLDINGS INC's latest trailing twelve months (TTM) CF - Equity stands at $ -227K.
  • Over the past 5 years, MARAVAI LIFESCIENCES HOLDINGS INC's average CF - Equity has been $ 33.26M.
  • The median CF - Equity for MARAVAI LIFESCIENCES HOLDINGS INC during this period was $ 905K
  • MARAVAI LIFESCIENCES HOLDINGS INC reached its highest CF - Equity over the past 5 years at $ 293.46M.
  • The lowest CF - Equity recorded by MARAVAI LIFESCIENCES HOLDINGS INC in the same timeframe $ -331K

MARAVAI LIFESCIENCES HOLDINGS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
KROS : KEROS THERAPEUTICS INC $ 231.51MXNCR : XENCOR INC $ 210.01MRIGL : RIGEL PHARMACEUTICALS INC $ 2.52MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ 200.8MSTOK : STOKE THERAPEUTICS INC $ 10.65MRGNX : REGENXBIO INC $ 884KAKBA : AKEBIA THERAPEUTICS INC $ 91.26MVNDA : VANDA PHARMACEUTICALS INC $ 0DNA : GINKGO BIOWORKS HOLDINGS INC $ -4KANAB : ANAPTYSBIO INC $ 43.34M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

MRVI - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -331K

Minimum

Sep 30, 2024

$ 293.46M

Maximum

Sep 30, 2021

$ 33.26M

Average

$ 905K

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 118.57K with a standard deviation of $ 17.64M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.4M
average$ 118.57K
median$ 0
std$ 17.64M